ABSTRACT
The development and optimization of a series of quinolinylpurines as potent and selective PI3Kδ kinase inhibitors with excellent physicochemical properties are described. This medicinal chemistry effort led to the identification of 1 (AMG319), a compound with an IC50 of 16 nM in a human whole blood assay (HWB), excellent selectivity over a large panel of protein kinases, and a high level of in vivo efficacy as measured by two rodent disease models of inflammation.
Subject(s)
Adenosine/pharmacology , Autoimmune Diseases/prevention & control , Class I Phosphatidylinositol 3-Kinases/antagonists & inhibitors , Inflammation/prevention & control , Protein Kinase Inhibitors/pharmacology , Quinolines/pharmacology , Adenosine/chemistry , Adenosine/metabolism , Animals , Cells, Cultured , Class I Phosphatidylinositol 3-Kinases/chemistry , Class I Phosphatidylinositol 3-Kinases/metabolism , Crystallography, X-Ray , Disease Models, Animal , Drug Discovery , Female , Humans , Mice, Inbred BALB C , Mice, Transgenic , Models, Chemical , Models, Molecular , Molecular Structure , Protein Binding , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/metabolism , Protein Structure, Tertiary , Quinolines/chemistry , Quinolines/metabolism , Rats, Inbred Lew , Sf9 Cells , Structure-Activity RelationshipABSTRACT
Structure-based rational design led to the synthesis of a novel series of potent PI3K inhibitors. The optimized pyrrolopyridine analogue 63 was a potent and selective PI3Kß/δ dual inhibitor that displayed suitable physicochemical properties and pharmacokinetic profile for animal studies. Analogue 63 was found to be efficacious in animal models of inflammation including a keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheumatoid arthritis. These studies highlight the potential therapeutic value of inhibiting both the PI3Kß and δ isoforms in the treatment of a number of inflammatory diseases.
Subject(s)
Drug Discovery , Drug Evaluation, Preclinical , Phosphoinositide-3 Kinase Inhibitors , Protein Kinase Inhibitors/pharmacology , Models, MolecularABSTRACT
The natural product prodigiosin 1, often described as an H+/Cl- symport cotransporter, can transport Cl- across lipid vesicles via an anion exchange (or antiport) mechanism.